About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04842760

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

Platelets are essential blood elements to maintain hemostasis. Quantitative or qualitative defects can be responsible of hemorrhagic (platelet disorders) or thrombotic (heparin induced thrombocytopeni...

Lead sponsor: Centre Hospitalier Universitaire, Amiens•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Maïlys LE GUYADER, MD

CONTACT

03.22.08.70.00 leguyader.mailys@chu-amiens.fr

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire, Amiens

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•male or female patient for whom a blood test was prescribed in a context of diagnosis of platelet dysfunction or HIT

Exclusion Criteria

•minor patients
•patients who have opposed the use of their personal data for research work.

Related studies

RECRUITINGPhase 1

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

NCT06090669 · Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies

RECRUITINGPhase 2

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

NCT06261060 · Familial Platelet Disorder, Hematopoietic

RECRUITINGPhase 1

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

NCT06414889 · RUNX1 Familial Platelet Disorder

Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)

NCT05196789 · Inherited BMF Syndrome, Inherited Platelet Disorder, and more

Preoperative Hemogram Parameters and BRAF Molecular Test Detected by Bethesda 3 Cytology.

NCT06539702 · Blood Platelet Disorder, BRAF V600E, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 10, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateJun 2021

Last updatedFeb 10, 2023

Condition

Platelet Disorder Heparin-induced Thrombocytopenia Platelet Activation Platelet Aggregation

Locations shown

CHU Amiens

Amiens

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 10, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions